Ilex Capital Partners (UK) LLP
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1985486
London, X0
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,578,440
+$32,350,799 QoQ
Shares Held
154,736
+68.2% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
#225
of 2,606 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ilex Capital Partners (UK) LLP holds $222,464,235 across 5 Diagnostics & Research names. TMO ranks #1 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
154,736 | $77,578,440 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
370,977 | $71,680,175 | |
| 3 | ILMN |
Illumina, Inc.
|
289,131 | $50,837,903 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
81,193 | $18,413,760 | |
| 5 | RVTY |
Revvity, Inc.
|
35,538 | $3,953,957 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,578,440 | 154,736 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $45,227,641 | 92,014 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $56,982,872 | 109,534 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $80,595,879 | 145,743 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,585,109 | 11,330 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||